explore -WSS

explore

author：knowledge 2025-08-11 11:44:06 - browse：42

The activities director of a nursing home stands and holds the hand of a resident in a wheelchair while another staff member holds the hand of a resident, also in a wheelchair, on the right. Two other residents in wheelchairs sit in the same circle — politics coverage from STAT — Jeff Chiu/AP

A new federal lawsuit challenging the Biden administration’s new minimum nursing home staffing rule lays out the worst-case scenario: Hundreds of long-term care facilities forced to downsize or close, tens of thousands of vulnerable seniors displaced, and countless others waiting longer for care.

Not only that, the complaint argues that the Centers for Medicare and Medicaid Services lacked the authority to implement the final rule. The lawsuit was filed on Thursday by the American Health Care Association, a Washington, D.C.-based trade group of more than 14,000 nursing homes, along with its Texas counterpart and three Texas nursing homes.

“The Final Rule thus promises to be a nightmare not only for owners and operators of nursing homes, but also for the vulnerable residents they serve, in direct derogation of CMS’s statutory mandate,” according to the complaint, filed in the Northern District of Texas. In addition to CMS, it lists the department of Health and Human Services and secretary Xavier Becerra as defendants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： STAT Virtual Event: How to Increase Diversity in Clinical Trials

focus

WSS

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Address the ethical violations that led to 'Three Identical Strangers'

Ionis has late

Boston's new lab space is opening empty

How many hemophilia patients actually want gene therapy?

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Would Medicare drug price negotiations stall in a shutdown?

Dobbs anniversary: the lost opportunity of abortion as health care

Paxlovid should be available without a positive Covid test

What does generative AI mean for health care? We asked experts

EPA limits use of carcinogenic gas for sterilizing medical devices

New air purifier tech could be key to improving indoor air quality

Health tech startups drop sharply from 2021 highs

focus

Readout Newsletter: CAR

FDA advisers back CAR

Paxlovid should be available without a positive Covid test

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Menendez indictment could see pharma lose a key ally

Data show record exodus of life scientists from academia

focus

focus

leisure time

focus